These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12904966)

  • 1. Effect of antipsychotics on cortical inhibition using transcranial magnetic stimulation.
    Daskalakis ZJ; Christensen BK; Chen R; Fitzgerald PB; Zipursky RB; Kapur S
    Psychopharmacology (Berl); 2003 Nov; 170(3):255-262. PubMed ID: 12904966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between cortical inhibition, antipsychotic treatment, and the symptoms of schizophrenia.
    Liu SK; Fitzgerald PB; Daigle M; Chen R; Daskalakis ZJ
    Biol Psychiatry; 2009 Mar; 65(6):503-9. PubMed ID: 18950746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of cortical GABAergic inhibition correlates with working memory impairment in recent onset schizophrenia.
    Takahashi S; Ukai S; Kose A; Hashimoto T; Iwatani J; Okumura M; Tsuji T; Shinosaki K
    Schizophr Res; 2013 May; 146(1-3):238-43. PubMed ID: 23523695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antipsychotic drugs on cortical thickness. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine.
    Roiz-Santiáñez R; Tordesillas-Gutiérrez D; Ortíz-García de la Foz V; Ayesa-Arriola R; Gutiérrez A; Tabarés-Seisdedos R; Vázquez-Barquero JL; Crespo-Facorro B
    Schizophr Res; 2012 Oct; 141(1):22-8. PubMed ID: 22884754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor circuit abnormalities in first-episode schizophrenia assessed with transcranial magnetic stimulation.
    Wobrock T; Schneider-Axmann T; Retz W; Rösler M; Kadovic D; Falkai P; Schneider M
    Pharmacopsychiatry; 2009 Sep; 42(5):194-201. PubMed ID: 19724982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased cortical inhibition in persons with schizophrenia treated with clozapine.
    Daskalakis ZJ; Christensen BK; Fitzgerald PB; Moller B; Fountain SI; Chen R
    J Psychopharmacol; 2008 Mar; 22(2):203-9. PubMed ID: 18308816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A transcranial magnetic stimulation study of the effects of olanzapine and risperidone on motor cortical excitability in patients with schizophrenia.
    Fitzgerald PB; Brown TL; Daskalakis ZJ; Kulkarni J
    Psychopharmacology (Berl); 2002 Jun; 162(1):74-81. PubMed ID: 12107621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation.
    Daskalakis ZJ; Christensen BK; Chen R; Fitzgerald PB; Zipursky RB; Kapur S
    Arch Gen Psychiatry; 2002 Apr; 59(4):347-54. PubMed ID: 11926935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic treatment with quetiapine increases the cortical silent period.
    Frank E; Landgrebe M; Poeppl TB; Schecklmann M; Kreuzer PM; Prasser J; Rupprecht R; Eichhammer P; Hajak G; Langguth B
    Schizophr Res; 2014 Jun; 156(1):128-32. PubMed ID: 24794881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects.
    Cohrs S; Röher C; Jordan W; Meier A; Huether G; Wuttke W; Rüther E; Rodenbeck A
    Psychopharmacology (Berl); 2006 Mar; 185(1):11-8. PubMed ID: 16432682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairments in motor-cortical inhibitory networks across recent-onset and chronic schizophrenia: a cross-sectional TMS Study.
    Strube W; Wobrock T; Bunse T; Palm U; Padberg F; Malchow B; Falkai P; Hasan A
    Behav Brain Res; 2014 May; 264():17-25. PubMed ID: 24509248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigation of regional cerebral blood flow and tissue structure changes after acute administration of antipsychotics in healthy male volunteers.
    Hawkins PCT; Wood TC; Vernon AC; Bertolino A; Sambataro F; Dukart J; Merlo-Pich E; Risterucci C; Silber-Baumann H; Walsh E; Mazibuko N; Zelaya FO; Mehta MA
    Hum Brain Mapp; 2018 Jan; 39(1):319-331. PubMed ID: 29058358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antipsychotic drugs on brain morphometry. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine.
    Crespo-Facorro B; Roiz-Santiáñez R; Pérez-Iglesias R; Pelayo-Terán JM; Rodríguez-Sánchez JM; Tordesillas-Gutiérrez D; Ramírez M; Martínez O; Gutiérrez A; de Lucas EM; Vázquez-Barquero JL
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1936-43. PubMed ID: 18930104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actigraphic measurement of the effects of single-dose haloperidol and olanzapine on spontaneous motor activity in normal subjects.
    Kiang M; Daskalakis ZJ; Christensen BK; Remington G; Kapur S
    J Psychiatry Neurosci; 2003 Jul; 28(4):293-9. PubMed ID: 12921224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The Relationship of the Change in Symptoms and Cognitive Functions With the Change in Cortical Inhibition Parameters Measured by Transcranial Magnetic Stimulation: An Eight-Week Follow-Up Study].
    Yıldız Mİ; Temuçin Ç; Ertuğrul A
    Turk Psikiyatri Derg; 2015; 26(3):161-71. PubMed ID: 26364170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia.
    Arakawa R; Okumura M; Ito H; Takano A; Takahashi H; Takano H; Maeda J; Okubo Y; Suhara T
    J Clin Psychiatry; 2010 Sep; 71(9):1131-7. PubMed ID: 20361897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.
    Crespo-Facorro B; Rodríguez-Sánchez JM; Pérez-Iglesias R; Mata I; Ayesa R; Ramirez-Bonilla M; Martínez-Garcia O; Vázquez-Barquero JL
    J Clin Psychiatry; 2009 Apr; 70(5):717-29. PubMed ID: 19389335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-arrangements of gene transcripts at glutamatergic synapses after prolonged treatments with antipsychotics: A putative link with synaptic remodeling.
    Buonaguro EF; Iasevoli F; Marmo F; Eramo A; Latte G; Avagliano C; Tomasetti C; de Bartolomeis A
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():29-41. PubMed ID: 28235555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficient inhibitory cortical networks in antipsychotic-naive subjects at risk of developing first-episode psychosis and first-episode schizophrenia patients: a cross-sectional study.
    Hasan A; Wobrock T; Grefkes C; Labusga M; Levold K; Schneider-Axmann T; Falkai P; Müller H; Klosterkötter J; Bechdolf A
    Biol Psychiatry; 2012 Nov; 72(9):744-51. PubMed ID: 22502988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: A comparison of efficacy, safety, and side effects.
    Boettger S; Jenewein J; Breitbart W
    Palliat Support Care; 2015 Aug; 13(4):1079-85. PubMed ID: 25191793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.